Status:
COMPLETED
Infusion Rate and Volume Kinetics for Hyperoncotic Albumine in Healthy Subjects
Lead Sponsor:
University Hospital, Linkoeping
Conditions:
Edema Secondary
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
Treatment with colloidal solutions has during long time been a cornerstone within intensive care. Lately there has been a shift from synthetic colloids to natural albumine. One of these solutions is ...
Detailed Description
Difference in volume expansion as well as fluid recruitment from the tissues depending on infusion rate is of interest. Plasma volume expansion is measured using hemoglobin as a marker and fluid recr...
Eligibility Criteria
Inclusion
- \- Healthy, without allergies and with the age 18 years or above
Exclusion
- Heart failure
- Signs of kidney injury/failure
- Severe allergies
- Pregnancy
Key Trial Info
Start Date :
February 24 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2019
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT03453320
Start Date
February 24 2018
End Date
January 31 2019
Last Update
May 29 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Intensive Care Unit, University Hospital
Linköping, Sweden